Personalized alcohol treatment options tested for liver disease patients
NCT ID NCT06269510
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aims to see if giving patients with alcohol-related liver disease customized alcohol treatment choices increases their participation in therapy or support groups. Researchers will enroll 268 adults from University of Michigan clinics and hospitals. The main goal is to measure how many patients start treatment and to correct any misunderstandings about their options.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL-RELATED LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Henry Ford Health
RECRUITINGDetroit, Michigan, 48202, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smartphone app tame Alcohol-Related liver disease?
- Can a smarter scan make liver testing more reliable?
- A new Anti-Rejection strategy may spare kidney function after liver transplant
- Can a quick MRI scan reveal what a healthy Child's liver looks like?
- Blood test and AI could spot liver cancer early, saving lives
- Food flavors on the breath may reveal hidden liver disease